Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.26.9 (
ribonuclease
)
6,589
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In search of synthetic high affinity ligands for the
mannose receptor
, we synthesized a series of lysine-based oligomannosides containing two (M2L) to six (M6L5) terminal alpha-D-mannose groups that are connected with the backbone by flexible elongated spacers (16 A). The synthesized cluster mannosides were all able to displace binding of biotinylated
ribonuclease
B and tissue-type plasminogen activator to isolated human
mannose receptor
. The affinity of these cluster mannosides for the
mannose receptor
was continuously enhanced from 18-23 microM to 0.5-2.6 nM, with mannose valencies increasing from two to six. On average, expansion of the cluster mannoside with an additional alpha-D-mannose group resulted in a 10-fold increase in its affinity for the
mannose receptor
. M3L2 to M6L5 displayed negative cooperative inhibition of ligand binding to the
mannose receptor
, suggesting that binding of these mannosides involves multiple binding sites. The nanomolar affinity of the most potent ligand, the hexamannoside M6L5 makes it the most potent synthetic cluster mannoside for the
mannose receptor
yet developed. As a result of its high affinity and accessible synthesis, M6L5 not only is a powerful tool to study the mechanism of ligand binding by the
mannose receptor
, but it is also a promising targeting device to accomplish cell-specific delivery of genes and drugs to liver endothelial cells or macrophages in bone marrow, lungs, spleen, and atherosclerotic plaques.
...
PMID:Lysine-based cluster mannosides that inhibit ligand binding to the human mannose receptor at nanomolar concentration. 891 Apr 12
The 175-kDa
mannose receptor
is one of the receptors that mediates the clearance of tissue-type plasminogen activator (t-PA). The affinity of t-PA for the
mannose receptor
is much higher than the affinity of other high-mannose-type oligosaccharide-containing glycoproteins. In order to find an explanation for this high affinity, we studied the biochemical interaction of various forms of t-PA with the isolated human
mannose receptor
in several in vitro binding assays. t-PA showed a high affinity (Ki = 0.2 nM) for the
mannose receptor
and the interaction could be fully inhibited by mannan or polyclonal antibodies against the
mannose receptor
. The interaction was not affected by non-glycosylated t-PA. The high affinity differed slightly between t-PAs synthesized by various cell types (range Ki 0.2-0.7 nM) and between various glycoforms of t-PA. No statistically significant difference in affinity between t-PA and t-PA complexed to inhibitors was observed. In contrast to intact t-PA, a trypsin digest of t-PA had a low affinity (Ki = 0.5 microM) for the
mannose receptor
. Both intact and trypsin digests of the high-mannose-type oligosaccharide-containing glycoproteins
ribonuclease
B and ovalbumin had a low affinity (Ki 0.5-1.5 microM) for the
mannose receptor
. We conclude that neither protein-protein interactions, nor the complex-type oligosaccharides and the fucose residue on t-PA contribute significantly to the high-affinity binding of t-PA. We suggest that the conformation of the high-mannose-type oligosaccharide on t-PA is influenced by the protein moiety of t-PA in such a way that the oligosaccharide has a high affinity for the
mannose receptor
.
...
PMID:Role of carbohydrate and protein in the binding of tissue-type plasminogen activator to the human mannose receptor. 949 74
One function proposed for the
mannose receptor
found on dendritic cells as well as on macrophages and hepatic endothelial cells is in enhancing uptake and processing of glycoprotein antigens for presentation by major histocompatibility complex (MHC) class II molecules. In this study, a direct assessment of the possible role of the
mannose receptor
in this process was made in the absence of other endocytic receptors that can internalize glycoproteins. Presentation of RNase A and B peptides was compared in transfected fibroblasts coexpressing the
mannose receptor
and MHC class II molecules. RNase B bears a high-mannose oligosaccharide and is a ligand for the
mannose receptor
, whereas RNase A is not glycosylated and is taken up by pinocytosis. Incubation of RNase A or B with the transfected cells resulted in identical stimulation of
ribonuclease
-specific T cells, indicating that endocytosis of the glycosylated protein by the
mannose receptor
does not enhance presentation of this antigen. The postulated role of the
mannose receptor
in presentation of glycoprotein-derived antigen is reevaluated in light of these results.
...
PMID:The mannose receptor fails to enhance processing and presentation of a glycoprotein antigen in transfected fibroblasts. 1519 5
Omega-1, a glycosylated T2
ribonuclease
(
RNase
) secreted by Schistosoma mansoni eggs and abundantly present in soluble egg antigen, has recently been shown to condition dendritic cells (DCs) to prime Th2 responses. However, the molecular mechanisms underlying this effect remain unknown. We show in this study by site-directed mutagenesis of omega-1 that both the glycosylation and the
RNase
activity are essential to condition DCs for Th2 polarization. Mechanistically, we demonstrate that omega-1 is bound and internalized via its glycans by the
mannose receptor
(MR) and subsequently impairs protein synthesis by degrading both ribosomal and messenger RNA. These experiments reveal an unrecognized pathway involving MR and interference with protein synthesis that conditions DCs for Th2 priming.
...
PMID:Schistosome-derived omega-1 drives Th2 polarization by suppressing protein synthesis following internalization by the mannose receptor. 2296 4